Jenscare Scientific Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	90.59	-	-	-	-
Cost of Revenue	8.07	-	-	-	-
Gross Profit	82.52	-	-	-	-
Selling, General & Admin	128.44	68.18	150.31	219.7	238.51
Research & Development	183.61	142.64	288.15	291.58	265.34
Operating Expenses	314.02	210.82	438.46	511.28	503.84
Operating Income	-231.5	-210.82	-438.46	-511.28	-503.84
Interest Expense	-0.87	-0.29	-0.14	-0.11	-0.13
Interest & Investment Income	13.82	11.25	19.33	8.36	1.77
Earnings From Equity Investments	-	-	18.95	16.17	1.34
Currency Exchange Gain (Loss)	-13.47	2.91	3.17	34.62	-6.84
Other Non Operating Income (Expenses)	-42.11	7.06	18.24	10.62	0.54
EBT Excluding Unusual Items	-274.12	-189.89	-378.92	-441.62	-507.16
Gain (Loss) on Sale of Investments	1.75	10.84	-0.17	0.72	6.49
Gain (Loss) on Sale of Assets	-0.04	-0.09	-0.01	-0.01	-
Asset Writedown	-0.29	-6.69	-	-	-
Pretax Income	-272.7	-185.83	-379.1	-440.91	-500.67
Earnings From Continuing Operations	-272.7	-185.83	-379.1	-440.91	-500.67
Minority Interest in Earnings	1.48	8.32	7.36	1.6	0.16
Net Income	-271.23	-177.51	-371.74	-439.31	-500.52
Net Income to Common	-271.23	-177.51	-371.74	-439.31	-500.52
Shares Outstanding (Basic)	425	409	417	365	338
Shares Outstanding (Diluted)	425	409	417	365	338
Shares Change (YoY)	4.02%	-1.97%	14.17%	7.96%	21.43%
EPS (Basic)	-0.64	-0.43	-0.89	-1.20	-1.48
EPS (Diluted)	-0.64	-0.43	-0.89	-1.20	-1.48
Free Cash Flow	-78.24	-288.81	-300.64	-180.14	-155.17
Free Cash Flow Per Share	-0.18	-0.71	-0.72	-0.49	-0.46
Gross Margin	91.09%	-	-	-	-
Operating Margin	-255.55%	-	-	-	-
Profit Margin	-299.41%	-	-	-	-
Free Cash Flow Margin	-86.37%	-	-	-	-
EBITDA	-220.42	-201.62	-429.68	-504.82	-500.44
EBITDA Margin	-243.32%	-	-	-	-
D&A For EBITDA	11.08	9.2	8.78	6.46	3.41
EBIT	-231.5	-210.82	-438.46	-511.28	-503.84
EBIT Margin	-255.55%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.